감염성 호흡기 질환 진단 시장 : 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global infectious respiratory disease diagnostics market size is expected to reach USD 19.23 Billion in 2034 from USD 14.71 Billion in 2025, growing at a CAGR of 3.02 during 2026-2034.The Global Synthetic Small Molecule API Market is experiencing steady growth driven by the strong demand for pharmaceutical drugs across therapeutic areas. Small molecule active pharmaceutical ingredients remain essential for treating chronic conditions such as cardiovascular diseases, oncology, neurological disorders, and diabetes. The expansion of generic drug production is further stimulating API manufacturing. Increasing outsourcing to contract manufacturing organizations helps pharmaceutical companies optimize costs and improve efficiency. Rising global healthcare expenditure is also supporting continuous market expansion.

Advancements in chemical synthesis technologies and process optimization are improving product quality and scalability. Manufacturers are focusing on compliance with stringent regulatory standards to ensure safety and efficacy. The growing pipeline of small molecule drug candidates continues to create opportunities for API suppliers. Emerging economies are investing heavily in pharmaceutical infrastructure to strengthen domestic production capabilities. Additionally, demand for high-potency APIs is rising due to increasing oncology drug development.

In the future, the market is expected to benefit from sustainable and green chemistry initiatives that reduce environmental impact. Strategic collaborations between pharmaceutical companies and API producers will enhance supply chain resilience. Technological innovations such as continuous manufacturing processes are improving operational efficiency. Expanding healthcare access in developing countries will create new growth avenues. Overall, consistent innovation and increasing drug demand will ensure steady market progression.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments)
• Consumables
• Services

By Sample

• Saliva
• Nasopharyngeal Swabs (NPS)
• Anterior Nasal Region
• Blood
• Others

By Application

• COVID-19
• Influenza
• Respiratory Syncytial Virus (RSV)
• Tuberculosis
• Streptococcus Testing
• Other Respiratory Disease Testing

By Technology

• Immunoassay
• Molecular Diagnostics
• Microbiology
• Other Technologies

By End Use

• Hospitals
• Diagnostic Laboratories
• Physician Offices
• Others

COMPANIES PROFILED

• Abbott Laboratories, Becton Dickinson and Company (BD), bioMerieux SA, Bio-Rad Laboratories, Inc., Bruker Corporation (ELITechGroup / Hain Lifescience GmbH), Certest Biotec S.L., Danaher Corporation (Cepheid), DiaSorin S.p.A. (Luminex Corporation), F. Hoffmann-La Roche Ltd, ., (Roche Diagnostics / GenMark Diagnostics), Hologic, Inc., QIAGEN N.V., QuidelOrtho Corporation, SD Biosensor, Inc. (Meridian Bioscience, Inc.), Seegene Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY SAMPLE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Sample
• 5.2. Saliva Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Nasopharyngeal Swabs (NPS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Anterior Nasal Region Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. COVID-19 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Influenza Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Respiratory Syncytial Virus (RSV) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Tuberculosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Streptococcus Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Respiratory Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Technology
• 7.2. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Microbiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY END USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End Use
• 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Physician Offices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Sample
  • 9.2.3 By Application
  • 9.2.4 By Technology
  • 9.2.5 By End Use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Sample
  • 9.3.3 By Application
  • 9.3.4 By Technology
  • 9.3.5 By End Use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Sample
  • 9.4.3 By Application
  • 9.4.4 By Technology
  • 9.4.5 By End Use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Sample
  • 9.5.3 By Application
  • 9.5.4 By Technology
  • 9.5.5 By End Use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Sample
  • 9.6.3 By Application
  • 9.6.4 By Technology
  • 9.6.5 By End Use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott Laboratories
  • 11.2.2 Becton Dickinson And Company (BD)
  • 11.2.3 BioMerieux SA
  • 11.2.4 Bio-Rad LaboratoriesInc
  • 11.2.5 Bruker Corporation (ELITechGroup / Hain Lifescience GmbH)
  • 11.2.6 Certest Biotec S.L
  • 11.2.7 Danaher Corporation (Cepheid)
  • 11.2.8 DiaSorin S.p.A. (Luminex Corporation)
  • 11.2.9 F. Hoffmann-La Roche Ltd. (Roche Diagnostics / GenMark Diagnostics)
  • 11.2.10 HologicInc
  • 11.2.11 QIAGEN N.V
  • 11.2.12 QuidelOrtho Corporation
  • 11.2.13 SD Biosensor, Inc. (Meridian Bioscience, Inc.)
  • 11.2.14 Seegene Inc
  • 11.2.15 Siemens Healthineers AG
  • 11.2.16 Thermo Fisher Scientific Inc